What the UBRELVY TV commercial - No-Exit-in-Sight Migraine Medicine: $0 is about.
UBRELVY is a medication that helps to relieve migraine headaches. In a recent television commercial, the medicine is highlighted as the perfect choice for individuals who suffer from migraines with no visible relief in sight.
The TV spot features tennis superstar Serena Williams, who has become an advocate for the medication. In the commercial, we see Williams speaking about her experience with migraines and how UBRELVY has helped her manage the pain. Williams mentions that the medication can work in as little as an hour, helping to restore normalcy and provide relief to migraine sufferers.
One of the most notable aspects of the commercial is the 'No-Exit-in-Sight Migraine Medicine: $0 message that appears at the end. The message highlights the fact that individuals who meet the eligibility criteria can obtain UBRELVY for no cost. This is an exciting prospect for those who have been putting off seeking treatment due to financial constraints.
The video also features stunning visuals, with Williams posing in a variety of athletic outfits on the tennis court. The energetic background music also helps to capture the spirit of determination and resilience that migraine sufferers must possess to get through their pain.
Overall, the UBRELVY TV spot featuring Serena Williams is a powerful reminder that there is hope for those who suffer from migraines. With this medication, individuals can manage their pain and get back to living their best lives.
UBRELVY TV commercial - No-Exit-in-Sight Migraine Medicine: $0 produced for
UBRELVY
was first shown on television on January 17, 2022.
Frequently Asked Questions about ubrelvy tv spot, 'no-exit-in-sight migraine medicine: $0' featuring serena williams
Behind every migraine journey, there's a story. After years of struggling with migraine, tennis superstar Serena Williams and gold medal-winning gymnast Aly Raisman have found relief with UBRELVY.
Ubrelvy has been found effective for the treatment of migraine in adults. The American Headache Society recommends Ubrelvy in certain situations. (For more information, see the “Who is Ubrelvy prescribed for” section just above.) To learn about the drug's clinical studies, see the prescribing information for Ubrelvy.
What Are Side Effects of Ubrelvy?
- nausea,
- drowsiness,
- rash,
- itching,
- swelling of the face, tongue or throat,
- severe dizziness, and.
- trouble breathing.
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
about $130
Each tablet costs about $130. People normally take one 50 or 100 mg tablet to relieve migraine symptoms at the start of a migraine episode. However, they may need to take a second tablet if the first doesn't work. That means the average price per migraine episode can cost anywhere from $130 to $260.
No, Ubrelvy (generic name: ubrogepant) is not a narcotic (opioid) and is not a controlled substance. It does not cause addiction. Ubrelvy, from Allergan, is classified as an oral calcitonin gene-related peptide (CGRP) receptor antagonist (also called a "gepant"). It comes as an oral tablet.
UBRELVY LIST PRICE. The Wholesale Acquisition Cost (WAC), also known as the list price for one dose of UBRELVY is $98.40, or $983.99 per month, as of January 2023. The WAC may not reflect the price paid by patients. Call 1 (800) 678-1605 (option 4) to find out how much UBRELVY will cost for you.
Note: Ubrelvy isn't meant to be taken every day. You should only take it when you have a migraine attack. And, you shouldn't take Ubrelvy to treat more than 8 migraine attacks every month (30 days). It's not known if it's safe to take the drug more often than this.
(CGRP antagonist is the class of drugs that Ubrelvy belongs to.) So, it's possible you may have hair loss with Ubrelvy. If you have bothersome hair loss with Ubrelvy, talk with your doctor. They can suggest ways to manage your hair loss.
Acute medications for migraine
- Almotriptan (Axert)
- Eletriptan (Relpax)
- Frovatriptan (Frova)
- Naratriptan (Amerge)
- Rizatriptan (Maxalt)
- Sumatriptan (Alsuma, Imitrex, Onzetra, Sumavel, Zembrace)
- Zolmitriptan (Zomig)
UBRELVY LIST PRICE. The Wholesale Acquisition Cost (WAC), also known as the list price for one dose of UBRELVY is $98.40, or $983.99 per month, as of January 2023. The WAC may not reflect the price paid by patients. Call 1 (800) 678-1605 (option 4) to find out how much UBRELVY will cost for you.
No, Ubrelvy (generic name: ubrogepant) is not a narcotic (opioid) and is not a controlled substance. It does not cause addiction. Ubrelvy, from Allergan, is classified as an oral calcitonin gene-related peptide (CGRP) receptor antagonist (also called a "gepant").